[Current methods of treatment of acute lymphoblastic leukemia in children].
D000208:Acute Disease; D000367:Age Factors; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D001215:Asparaginase / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D008938:Mitosis / Q000187:drug effects; D009503:Neutropenia / Q000150:complications; D011241:Prednisone / Q000627:therapeutic use; D012075:Remission, Spontaneous; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D014750:Vincristine; D015122:Mercaptopurine; D001215:Asparaginase; D011241:Prednisone; D008727:Methotrexate
Współczesne metody leczenia ostrej białaczki limfoblastycznej u dzieci